BURLINGTON, N.C., July 29, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today PGDx elio™ tissue complete has been CE-marked under the European Union’s (EU) new In Vitro Diagnostic Regulation (IVDR).

WALTHAM, Mass., July 29, 2025 /PRNewswire/ — Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to announce that its LungVision advanced imaging system has received regulatory approval from ANVISA, Brazil’s National Health Surveillance Agency. This approval marks another significant step forward in the company’s mission to improve early and accurate lung cancer diagnosis around the world.

Cortisol is a crucial hormone that regulates many important bodily functions like blood pressure and metabolism, and imbalances of this stress hormone can lead to health problems.

Deep brain stimulation (DBS) is a widely used surgical treatment for neurological disorders such as Parkinson’s disease, essential tremor, and obsessive–compulsive disorder. The procedure involves implanting electrodes into specific brain regions to regulate abnormal activity.

Circulating tumor cells (CTCs) refer to cancer cells that have broken off from a primary tumor. These tumor cells can travel through the blood in the circulatory system and lodge themselves in other organs to cause secondary tumors. Therefore, the detection and subsequent characterization of CTCs from blood can help in the clinical diagnosis and treatment of various cancers. However, the efficient capture of CTCs from blood has been proven to be difficult.

A new swallowable device called PRIM (Pill for ROS-responsive Inflammation Monitoring) could someday make tracking inflammatory bowel disease (IBD)—a chronic condition that causes inflammation in the digestive tract—as simple as checking the color of your stool. Researchers from Mass General Brigham and the University of Toronto designed and tested the device in preclinical models.

A multidisciplinary team at UT Southwestern Medical Center has developed an AI-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, published in npj Digital Medicine, could dramatically reduce the time needed to create analysis-ready data for research studies.

New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased cancer cells, acting like molecular flags that signal immune cells to attack and destroy the threats.